Or Refractory B-cell Acute Lymphoblastic Leukemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-01-06
Clinical Trial Update: CART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating CART19 cell therapy in patients with relapsed or refractory B-cell acute lymphoblastic leukemia and rela…